Copyright
©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 111165
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.111165
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.111165
Table 1 Comparison of clinical data between diabetic osteoporosis and type 2 diabetes patients, mean ± SD
| Group | n | Age (years) | BMI (kg/m2) | Fasting C-peptide (ng/mL) | FBG (mmol/L) | HbA1c (%) | MicroRNA335-3p | PTGS2 (ng/mL) |
| DM | 32 | 56.63 ± 8.42 | 24.36 ± 1.91 | 2.29 ± 1.21 | 9.26 ± 1.78 | 9.19 ± 1.13 | 2.86 (2.25, 3.36) | 10.52 (8.25, 12.91) |
| DOP | 30 | 65.40 ± 8.60 | 21.12 ± 1.52 | 1.29 ± 0.59 | 10.75 ± 2.23 | 10.28 ± 2.28 | 1.56 (1.03, 2.52) | 15.03 (12.66, 16.77) |
| Z/t | 4.06a | -7.44a | -4.10a | 2.88a | 2.62a | -5.072a | -5.163a |
Table 2 Factors affecting diabetic osteoporosis in binary logistic regression analysis
- Citation: Shao C, Zhang LJ, Song YL, Wang YQ, Zha XJ, Li J, Ye CS, Chen LL, Chen MW, Jin GX. Endothelial cell-derived exosomes inhibit high glucose-induced osteoblast ferroptosis by activating microRNA-335-3p/prostaglandin endoperoxide synthase 2. World J Diabetes 2026; 17(1): 111165
- URL: https://www.wjgnet.com/1948-9358/full/v17/i1/111165.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i1.111165
